BR112018003150A2 - lisobactina para uso no tratamento da mastite bovina - Google Patents

lisobactina para uso no tratamento da mastite bovina

Info

Publication number
BR112018003150A2
BR112018003150A2 BR112018003150-0A BR112018003150A BR112018003150A2 BR 112018003150 A2 BR112018003150 A2 BR 112018003150A2 BR 112018003150 A BR112018003150 A BR 112018003150A BR 112018003150 A2 BR112018003150 A2 BR 112018003150A2
Authority
BR
Brazil
Prior art keywords
lisobactin
bovine mastitis
treating bovine
treating
mastitis
Prior art date
Application number
BR112018003150-0A
Other languages
English (en)
Inventor
Schiffer Guido
Fälker Stefan
Daube Gert
Fraatz Kristine
Wiehl Wolfgang
Köbberling Johannes
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of BR112018003150A2 publication Critical patent/BR112018003150A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção se refere à lisobactina para uso no tratamento da mastite bovina. (fig. 3)
BR112018003150-0A 2015-08-17 2016-08-16 lisobactina para uso no tratamento da mastite bovina BR112018003150A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15181209.6 2015-08-17
EP15181209 2015-08-17
PCT/EP2016/069380 WO2017029271A1 (en) 2015-08-17 2016-08-16 Lysobactin for use in the treatment of bovine mastitis

Publications (1)

Publication Number Publication Date
BR112018003150A2 true BR112018003150A2 (pt) 2018-09-25

Family

ID=53871958

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018003150-0A BR112018003150A2 (pt) 2015-08-17 2016-08-16 lisobactina para uso no tratamento da mastite bovina

Country Status (27)

Country Link
US (2) US20180346518A1 (pt)
EP (1) EP3337494B1 (pt)
JP (1) JP6921805B2 (pt)
KR (1) KR20180040674A (pt)
CN (1) CN107921088B (pt)
AR (1) AR105728A1 (pt)
AU (1) AU2016310221B2 (pt)
BR (1) BR112018003150A2 (pt)
CA (1) CA2995648C (pt)
CO (1) CO2018001531A2 (pt)
CR (1) CR20180110A (pt)
DK (1) DK3337494T3 (pt)
ES (1) ES2788734T3 (pt)
HR (1) HRP20200427T1 (pt)
HU (1) HUE048864T2 (pt)
IL (1) IL257342A (pt)
LT (1) LT3337494T (pt)
MX (1) MX2018002020A (pt)
PE (1) PE20180574A1 (pt)
PH (1) PH12018500339A1 (pt)
PL (1) PL3337494T3 (pt)
PT (1) PT3337494T (pt)
RU (1) RU2741764C2 (pt)
SI (1) SI3337494T1 (pt)
TW (1) TW201717991A (pt)
WO (1) WO2017029271A1 (pt)
ZA (1) ZA201801788B (pt)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1266247C (en) * 1985-03-25 1990-02-27 ANTIBIOTIC PREPARED BY LYSOBACTER SP. SC14.067
JPH01132600A (ja) 1987-11-17 1989-05-25 Shionogi & Co Ltd カタノシンａおよびｂならびにその製造法
DE10320781A1 (de) * 2003-05-09 2004-11-25 Bayer Healthcare Ag Acylierte Nonadepsipeptide
DE102004051025A1 (de) * 2004-10-20 2006-04-27 Bayer Healthcare Ag Substituierte Nonadepsipeptide
DE102004051023A1 (de) 2004-10-20 2006-05-04 Bayer Healthcare Ag Desoxo-Nonadepsipeptide
DE102004051024A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Heterocyclyl-substituierte Nonadepsipeptide
DE102004053407A1 (de) * 2004-11-05 2006-05-11 Bayer Healthcare Ag Acylierte Nonadepsipeptide II
DE102004053410A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Cyclische Nonadepsipeptidamide
DE102004053409A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Verfahren zur gezielten Herstellung von Lysobactinfragmenten
DE102006003443A1 (de) 2006-01-25 2007-07-26 Aicuris Gmbh & Co. Kg Asparagin-10-substituierte Nonadepsipeptide
DE102006018080A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Lysobactinamide
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden

Also Published As

Publication number Publication date
AU2016310221B2 (en) 2021-08-05
AU2016310221A1 (en) 2018-03-01
AR105728A1 (es) 2017-11-01
EP3337494A1 (en) 2018-06-27
DK3337494T3 (da) 2020-05-25
CA2995648A1 (en) 2017-02-23
RU2018109421A (ru) 2019-09-19
US20180346518A1 (en) 2018-12-06
PT3337494T (pt) 2020-05-11
EP3337494B1 (en) 2020-03-11
US20230125394A1 (en) 2023-04-27
PE20180574A1 (es) 2018-04-04
RU2741764C2 (ru) 2021-01-28
WO2017029271A1 (en) 2017-02-23
PL3337494T3 (pl) 2020-09-07
LT3337494T (lt) 2020-04-10
CA2995648C (en) 2024-02-20
CR20180110A (es) 2018-04-27
HUE048864T2 (hu) 2020-08-28
MX2018002020A (es) 2018-06-15
JP6921805B2 (ja) 2021-08-18
IL257342A (en) 2018-03-29
PH12018500339A1 (en) 2018-08-20
HRP20200427T1 (hr) 2020-06-12
TW201717991A (zh) 2017-06-01
JP2018523677A (ja) 2018-08-23
ES2788734T3 (es) 2020-10-22
CN107921088B (zh) 2022-05-27
RU2018109421A3 (pt) 2019-11-13
CO2018001531A2 (es) 2018-07-10
ZA201801788B (en) 2019-10-30
CN107921088A (zh) 2018-04-17
SI3337494T1 (sl) 2020-06-30
KR20180040674A (ko) 2018-04-20

Similar Documents

Publication Publication Date Title
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
CY1123845T1 (el) Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
MD3209310T2 (ro) Compoziții care conțin tulpini bacteriene
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
BR112018009184A2 (pt) composições compreendendo cepas bacterianas
DK3889145T3 (da) 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme
CL2018002782A1 (es) Apósito modificado
BR112018070919A2 (pt) anticorpos anti-tim-3 e composições
EA201890204A1 (ru) Антибактериальные соединения
BR112017025005A2 (pt) composições compreendendo cepas baterianas
MD3307288T2 (ro) Compoziții care conțin tulpini bacteriene
MD3204024T2 (ro) Compoziții care conțin tulpini bacteriene
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
BR112018000776A2 (pt) métodos para tratamento de câncer usando apilimod
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
BR112018012304A2 (pt) composições e métodos para diminuir expressão de tau
BR112018070497A2 (pt) métodos e formulações farmacêuticas para tratamento de condições oculares
CO2018013020A2 (es) Combinaciones farmacéuticas para el tratamiento del cáncer
BR112017009265A2 (pt) apilimode para uso no tratamento do câncer colorretal
BR112017005272A2 (pt) uso de cisteamina no tratamento de infecções causadas por leveduras/bolores
MD3630136T2 (ro) Compoziții care cuprind tulpini bacteriene
TR201901228T4 (tr) Vortioksetin piroglutamat.

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]